Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation-Reference-Cited by-同舟云学术

Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation

Published:2005-05 Issue:5 Volume:7 Page:433-444
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Nilsson Jonas A.,Keller Ulrich B.,Baudino Troy A.,Yang Chunying,Norton Sara,Old Jennifer A.,Nilsson Lisa M.,Neale Geoffrey,Kramer Debora L.,Porter Carl W.,Cleveland John L.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference61 articles.

1. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice;Adams;Nature,1985

2. Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis;Askew;Oncogene,1991

3. Ornithine decarboxylase activity is critical for cell transformation;Auvinen;Nature,1992

4. p27 destruction: Cks1 pulls the trigger;Bartek;Nat. Cell Biol.,2001

5. Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss;Baudino;Mol. Cell,2003

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polyamine Anabolism Promotes Chemotherapy‐Induced Breast Cancer Stem Cell Enrichment;Advanced Science;2024-07-26

2. Polyamines regulate cell fate by altering the activity of histone-modifying enzymes;2024-07-03

3. Polyamine Dysregulation and Nucleolar Disruption in Alzheimer’s Disease;Journal of Alzheimer's Disease;2024-04-02

4. Preventing Cancer by Inhibiting Ornithine Decarboxylase: A Comparative Perspective on Synthetic vs. Natural Drugs;Chemistry & Biodiversity;2024-03-11

5. Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial;British Journal of Cancer;2024-01-10